KD-332 Phase III study

A phase III study of KD-332 multicenter, randomized, double-blind, parallel-group, comparative study of healthy children using DTaP vaccine and live-oral Polio vaccine as comparator vaccines.

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221042

Enrollment

315

Registered

2010-03-19

Start date

2010-03-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis of pertussis, diphtheria, tetanus, and poliomyelitis infection.

Interventions

investigational material(s) Generic name etc : KD-332 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Subcutaneous

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 3-90 months of age

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Immunogenicity Neutralizing antibody titers against type 1, type 2 and type 3 polio virus.	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026